Granahan Investment Management - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 186 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$1,365,000
+25.8%
22,490
+45.3%
0.02%
+8.7%
Q1 2021$1,085,000
-92.1%
15,478
-93.3%
0.02%
-92.6%
Q4 2020$13,764,000
-7.2%
230,011
-6.8%
0.31%
-38.6%
Q3 2020$14,833,000
+4.8%
246,730
-8.5%
0.50%
-1.8%
Q2 2020$14,149,000
+98.1%
269,663
+26.6%
0.51%
+33.0%
Q1 2020$7,142,000
-6.9%
213,013
+25.8%
0.38%
+9.1%
Q4 2019$7,669,000
+33.4%
169,291
+26.6%
0.35%
-13.3%
Q4 2018$5,751,000
-26.0%
133,693
-15.4%
0.41%
-3.3%
Q3 2018$7,767,000
+28.8%
158,036
-16.0%
0.42%
+16.0%
Q2 2018$6,028,000
+15.5%
188,086
+12.3%
0.36%
-3.7%
Q1 2018$5,217,000
-33.6%
167,469
-2.7%
0.38%
-39.0%
Q4 2017$7,859,000
+24.2%
172,152
+2.2%
0.62%
+17.0%
Q3 2017$6,326,000
-5.8%
168,464
+19.6%
0.53%
-14.7%
Q2 2017$6,719,000
+11.1%
140,855
+6.2%
0.62%
+2.0%
Q1 2017$6,050,000
-70.6%
132,665
-79.2%
0.61%
-14.0%
Q4 2016$20,558,000
-10.4%
636,480
-5.1%
0.71%
-6.0%
Q3 2016$22,948,000
+226.3%
670,610
+221.6%
0.75%
+193.4%
Q2 2016$7,033,000
-16.5%
208,500
+31.1%
0.26%
-16.3%
Q1 2016$8,424,000
+20.9%
159,000
+75.3%
0.31%
+27.5%
Q4 2015$6,965,000
-6.8%
90,700
-50.1%
0.24%
+3.9%
Q3 2015$7,472,000181,8000.23%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Prosight Management, LP 1,210,377$37,134,36611.77%
Gagnon Advisors, LLC 180,331$5,532,5554.63%
GAGNON SECURITIES LLC 565,429$17,347,3614.35%
ARDSLEY ADVISORY PARTNERS LP 310,000$9,510,8002.12%
RICE HALL JAMES & ASSOCIATES, LLC 968,485$29,713,1201.89%
AlphaCentric Advisors LLC 103,000$3,160,0401.79%
1492 Capital Management LLC 79,687$2,444,7971.58%
ARDSLEY ADVISORY PARTNERS LP 149,000$4,571,3201.02%
OUTFITTER FINANCIAL LLC 32,305$991,1170.93%
Rock Springs Capital Management LP 1,055,500$32,382,7400.87%
View complete list of PACIRA PHARMACEUTICALS INC shareholders